Log in to save to my catalogue

TXA2 attenuates allergic lung inflammation through regulation of Th2, Th9, and Treg differentiation

TXA2 attenuates allergic lung inflammation through regulation of Th2, Th9, and Treg differentiation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11060738

TXA2 attenuates allergic lung inflammation through regulation of Th2, Th9, and Treg differentiation

About this item

Full title

TXA2 attenuates allergic lung inflammation through regulation of Th2, Th9, and Treg differentiation

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2024-05, Vol.134 (9)

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

In lung, thromboxane A2 (TXA2) activates the TP receptor to induce proinflammatory and bronchoconstrictor effects. Thus, TP receptor antagonists and TXA2 synthase inhibitors have been tested as potential asthma therapeutics in humans. Th9 cells play key roles in asthma and regulate the lung immune response to allergens. Herein, we found that TXA2 r...

Alternative Titles

Full title

TXA2 attenuates allergic lung inflammation through regulation of Th2, Th9, and Treg differentiation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11060738

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11060738

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI165689

How to access this item